Physician profile
Peter Y Kim
NPI 1902832819
$10,995.15
in general payments reported to CMS, 2019-2025
12 companies · $244 in 2025
The $244 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,872 · 2020: $181 · 2021: $5,946 · 2022: $723 · 2023: $1,897 · 2024: $132 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,445 · Food and Beverage: $800 · Education: $27.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,445.25 |
| Food and Beverage | $800.23 |
| Education | $27.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,367.65 | 2021-2024 | |
| Medtronic Vascular, INC. | $1,978.59 | 2019-2020 | |
| Medtronic, INC. | $1,724.77 | 2021-2023 | Simulus, Corevalve Evolut R, Avalus |
| Edwards Lifesciences Corporation | $594.80 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $152.45 | 2020-2024 | Navitor |
| Getinge USA Sales, LLC | $46.17 | 2025 | Vasoview Hemopro 2 |
| Kci USA, INC. | $27.00 | 2023 | Prevena |
| Cook Medical LLC | $25.00 | 2023 | Evolution |
| Cgg Medical INC | $23.24 | 2024 | |
| Atricure, INC. | $19.62 | 2021 | |
| Lsi Solutions INC | $18.86 | 2025 | Ram |
| Ethicon US, LLC | $17.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.